Metallo-β-lactamase-producing <i>Pseudomonas aeruginosa</i>: epidemiology, diagnostic challenges and therapeutic strategies in the era of MDR/XDR resistance. [PDF]
Imeneo A +7 more
europepmc +1 more source
Siderophore-Enabled Delivery of Carbapenem and Metallo-β-Lactamase Inhibitor: A Promising Strategy against Multidrug-Resistant Pseudomonas aeruginosa. [PDF]
Safari S +6 more
europepmc +1 more source
<i>Escherichia coli</i> with penicillin-binding protein 3 insertions: implications for newer β-lactam/β-lactamase inhibitor combinations. [PDF]
Pitout JDD +4 more
europepmc +1 more source
Combination therapy with cefiderocol and minocycline for <i>Stenotrophomonas maltophilia</i> bacteremia in an obese patient on maintenance hemodialysis: A case report. [PDF]
Kameda K +5 more
europepmc +1 more source
Effective cefiderocol CSF penetration for treating <i>Stenotrophomonas maltophilia</i> ventriculitis. [PDF]
Ribera C +12 more
europepmc +1 more source
Emerging therapies and diagnostic innovations for multidrug-resistant infections in kidney allograft recipients: Challenges and future directions. [PDF]
Shetty A, Shankar M.
europepmc +1 more source
<i>In vitro</i> susceptibility of <i>Stenotrophomonas maltophilia</i> and other carbapenem non-susceptible Gram-negative rods in the Pacific Northwest to cefiderocol and aztreonam-avibactam. [PDF]
Bryan A +8 more
europepmc +1 more source
Update on the comparative <i>in vitro</i> activity of cefiderocol and four β-lactam-β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens. [PDF]
Wohlfarth E +8 more
europepmc +1 more source
Informamos de la aparición de no susceptibilidad al cefiderocol a partir de una subpoblación de Pseudomonas aeruginosa recuperada de un paciente sin antecedentes de exposición al cefiderocol.
Cesar A Arias +2 more
exaly +2 more sources

